Baker McKenzie advised Biocartis Group NV and its group companies on the deal. Biocartis Group NV and its group companies executed an enforcement by Biocartis’s secured...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised CellPoint on the deal. Walder Wyss has advised +ND Capital, while Baker McKenzie advised CellPoint and AboundBio. Galapagos, a fully...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Mithra Pharmaceuticals on the deal. Mithra Pharmaceuticals executed a €100 million equity funding from Goldman Sachs International. Mithra is a listed Belgian biotech company...
You must be a Standard 1 Year member to access this content.
